Life Science Danmark ApS: Financial statements 2024
CVR: 43271598
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Life Science Danmark ApS (CVR 43271598) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 17,710,896 and a net result of DKK 0 compared with DKK 0 the year before. That is a decrease of 3.3% compared with the year before. Equity in the 2024 report amounted to DKK 39,439. The solvency ratio was 3.6%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 17,710,896
- Profit/Loss
- DKK 0
- Equity
- DKK 39,439
- Total Assets
- DKK 1,110,694
- Employees
- 23
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 13, 2024, Dorte Clausen has joined the board of directors of Life Science Danmark ApS.
As of November 13, 2024, Pernille Pilgaard Jørgensen has joined the board of directors of Life Science Danmark ApS.
As of November 12, 2024, Dorte Clausen has left the board of directors of Life Science Danmark ApS.
As of November 12, 2024, Pernille Pilgaard Jørgensen has left the board of directors of Life Science Danmark ApS.
As of August 1, 2024, Erik Carp has left the board of directors of Life Science Danmark ApS.
Life Science Danmark ApS has published its annual report for 2023. Gross profit came to DKK 18,313,699, and the net result was DKK 0.
About Life Science Danmark ApS
Life Science Danmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2022. The company is registered under the industry Administrations- og kontorserviceaktiviteter. The management consists of Susie Stærk Ekstrand and Annette Meyer. The board consists of Stine Hasling Mogensen (chair), Pernille Pilgaard Jørgensen, Tanja Villumsen and Bill Majdecki Vestergaard. The company is owned by Pharmadanmark. The company has 26 employees (2026). In 2025, the company reported a gross profit of DKK 19,307,090 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 59,439.